Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chandrajit P Raut, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Chandrajit Raut and Elizabeth Baldini.
Chandrajit Raut
Connection Strength
5.413
Elizabeth Baldini
  1. Radiation therapy for extremity soft tissue sarcoma: in the absence of a clear survival benefit, why do we give it? Ann Surg Oncol. 2014 Aug; 21(8):2463-5.
    View in: PubMed
    Score: 0.577
  2. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol. 2013 May; 20(5):1494-9.
    View in: PubMed
    Score: 0.523
  3. High rates of histopathologic discordance in sarcoma with implications for clinical care. J Clin Oncol. 2011 May 20; 29(15_suppl):10065.
    View in: PubMed
    Score: 0.469
  4. Enhanced recovery after surgery pathway in patients with soft tissue sarcoma. Br J Surg. 2020 11; 107(12):1667-1672.
    View in: PubMed
    Score: 0.221
  5. Racial Differences in Extremity Soft Tissue Sarcoma Treatment in a Universally Insured Population. J Surg Res. 2020 06; 250:125-134.
    View in: PubMed
    Score: 0.214
  6. Screening populations at high risk for soft tissue sarcoma and surveillance following soft tissue sarcoma resection. J Surg Oncol. 2019 Oct; 120(5):882-890.
    View in: PubMed
    Score: 0.208
  7. Amputation for Extremity Sarcoma: Contemporary Indications and Outcomes. Ann Surg Oncol. 2018 Feb; 25(2):394-403.
    View in: PubMed
    Score: 0.184
  8. Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection. Ann Surg Oncol. 2018 Jan; 25(1):98-106.
    View in: PubMed
    Score: 0.183
  9. Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct; 24(11):3264-3270.
    View in: PubMed
    Score: 0.180
  10. Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy. Oncologist. 2017 10; 22(10):1265-1270.
    View in: PubMed
    Score: 0.178
  11. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):375-383.
    View in: PubMed
    Score: 0.175
  12. Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma. J Am Coll Surg. 2017 May; 224(5):876-883.
    View in: PubMed
    Score: 0.174
  13. Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Jun; 24(6):1588-1595.
    View in: PubMed
    Score: 0.173
  14. Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):360-366.
    View in: PubMed
    Score: 0.161
  15. Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists. Ann Surg Oncol. 2015 Sep; 22(9):2846-52.
    View in: PubMed
    Score: 0.155
  16. Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol. 2015 May; 22(5):1455-63.
    View in: PubMed
    Score: 0.149
  17. Role of post-operative radiation boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery. J Surg Oncol. 2014 Dec; 110(7):817-22.
    View in: PubMed
    Score: 0.147
  18. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014 Feb; 218(2):206-17.
    View in: PubMed
    Score: 0.139
  19. Paratesticular liposarcoma: unusual patterns of recurrence and importance of margins. Ann Surg Oncol. 2013 Jul; 20(7):2148-55.
    View in: PubMed
    Score: 0.134
  20. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013 Jul; 20(7):2140-7.
    View in: PubMed
    Score: 0.132
  21. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol. 2012 Nov; 19(12):3801-8.
    View in: PubMed
    Score: 0.128
  22. Cardiac angiosarcoma management and outcomes: 20-year single-institution experience. Ann Surg Oncol. 2012 Aug; 19(8):2707-15.
    View in: PubMed
    Score: 0.124
  23. Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):361-7.
    View in: PubMed
    Score: 0.112
  24. Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol. 2007 Dec; 14(12):3534-41.
    View in: PubMed
    Score: 0.091
  25. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO Open. 2021 06; 6(3):100170.
    View in: PubMed
    Score: 0.059
  26. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer. 2021 08 15; 127(16):2934-2942.
    View in: PubMed
    Score: 0.058
  27. Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face. J Contemp Brachytherapy. 2021 Apr; 13(2):172-178.
    View in: PubMed
    Score: 0.058
  28. Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy? Acta Oncol. 2021 Jan; 60(1):35-41.
    View in: PubMed
    Score: 0.056
  29. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020 10; 21(10):1366-1377.
    View in: PubMed
    Score: 0.056
  30. Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT. Sarcoma. 2020; 2020:7615248.
    View in: PubMed
    Score: 0.056
  31. Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet. Cancer. 2020 07 01; 126(13):3002-3012.
    View in: PubMed
    Score: 0.054
  32. A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas. Int J Radiat Oncol Biol Phys. 2019 06 01; 104(2):425-435.
    View in: PubMed
    Score: 0.050
  33. High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm. Plast Reconstr Surg Glob Open. 2014 Oct; 2(10):e229.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.